Inflammation

Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis
Philip J Mease, Atul A Deodhar, Désirée van der Heijde, Frank Behrens, Alan J Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak, Subhashis Banerjee

Annals of the Rheumatic Diseases Jun 2022, 81 (6) 815-822; DOI: 10.1136/annrheumdis-2021-221664
Response to: ‘Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease associated macrophage activation syndrome’ by Zhang et al
Francesca Minoia, Angelo Ravelli

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e100; DOI: 10.1136/annrheumdis-2020-218033
Comparison of MS score and HScore for the diagnosis of adult-onset Still’s disease-associated macrophage activation syndrome
Lei Zhang, Xiaopei Yang, Tian-Fang Li, Xiaojun Liu, Shengyun Liu

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e99; DOI: 10.1136/annrheumdis-2020-217917
In the shadow of antibodies: how T cells defend against COVID-19
David S Pisetsky, Kevin L Winthrop

Annals of the Rheumatic Diseases Jun 2022, 81 (6) 757-759; DOI: 10.1136/annrheumdis-2021-221952
Krüppel-like factor-4 and Krüppel-like factor-2 are important regulators of joint tissue cells and protect against tissue destruction and inflammation in osteoarthritis
Manabu Kawata, Takeshi Teramura, Philip Ordoukhanian, Steven R Head, Padmaja Natarajan, Aishwarya Sundaresan, Merissa Olmer, Hiroshi Asahara, Martin K Lotz

Annals of the Rheumatic Diseases May 2022, annrheumdis-2021-221867; DOI: 10.1136/annrheumdis-2021-221867
METTL3-mediated m⁶A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression
Xiang Chen, Wang Gong, Xiaoyan Shao, Tianshu Shi, Lei Zhang, Jian Dong, Yong Shi, Siyu Shen, Jianghui Qin, Qing Jiang, Baosheng Guo

Annals of the Rheumatic Diseases Jan 2022, 81 (1) 85-97; DOI: 10.1136/annrheumdis-2021-221091
Response to: Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé
Robert BM Landewé, Juergen Braun

Annals of the Rheumatic Diseases Apr 2022, annrheumdis-2022-222359; DOI: 10.1136/annrheumdis-2022-222359
Deletion of activin A in mesenchymal but not myeloid cells ameliorates disease severity in experimental arthritis
Vanessa Waltereit-Kracke, Corinna Wehmeyer, Denise Beckmann, Eugenie Werbenko, Julia Reinhardt, Fabienne Geers, Mike Dienstbier, Michelle Fennen, Johanna Intemann, Peter Paruzel, Adelheid Korb-Pap, Thomas Pap, Berno Dankbar

Annals of the Rheumatic Diseases Apr 2022, annrheumdis-2021-221409; DOI: 10.1136/annrheumdis-2021-221409
Concise report: a minimal-invasive method to retrieve and identify entheseal tissue from psoriatic arthritis patients
Milena L Pachowsky, Maria Gabriella Raimondo, Cong Xu, Simon Rauber, Koray Tascilar, Hannah Labinsky, Mario Vogg, Mina Saad Aziz Saad, David Simon, Juergen Rech, Alina Soare, Lars Braeuer, Arnd Kleyer, Georg Schett, Andreas Ramming

Annals of the Rheumatic Diseases Apr 2022, annrheumdis-2021-222061; DOI: 10.1136/annrheumdis-2021-222061
Low-ratio somatic NLRC4 mutation causes late-onset autoinflammatory disease
Jun Wang, Qiao Ye, Wenjie Zheng, Xiaomin Yu, Fang Luo, Ran Fang, Yaoyao Shangguan, Zhijun Du, Pui Y Lee, Taijie Jin, Qing Zhou

Annals of the Rheumatic Diseases Apr 2022, annrheumdis-2021-221708; DOI: 10.1136/annrheumdis-2021-221708

Main menu

Inflammation

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Inflammation

Pages